Thus, NTF2 overexpression generates a gene expression profile associated with improved prognosis in many cancers, consistent with our mouse studies showing that increasing NTF2 levels in metastatic melanoma cells reduces lung metastases and increases survival. The gene discussed is NUTF2; the disease is cancer.